As of 2016 there are several vaccines in development and three have gone to clinical trials. One clinical trial in Brazil used an inactivated vaccine for human immunotherapy. Another in Uzbekistan used an attenuated vaccine for human immunotherapy. Another in Brazil was vaccination of dogs to prevent those animals from spreading the disease. The dog vaccines are successful in providing immunity. In 2008, a vaccine for dogs was launched in Brazil, which is known as LeishTech, a recombinant protein based vaccine. In 2011 CaniLeish, a vaccine made with antigens from L. infantum, was licensed in Europe. Efforts are on ongoing to develop further vaccines for dogs with one second generation vaccine up for approval in Brazil as of 2017.
Leishmaniasis vaccine
Trypanosomiasis vaccine
Schistosomiasis vaccine
Hookworm vaccine
Edible vaccines
Malaria vaccine
Viral vector vaccine
Edible algae vaccine